Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
Reliance Retail acquired a controlling 60% stake in NetMeds parent Vitalic Health for ₹620 crore, marking its entry into e-pharmacy to challenge Amazon and PharmEasy. The deal proceeds amid regulatory uncertainty and opposition from chemist bodies, with Vitalic posting a net loss of ₹184.3 crore in FY20.
What happened
Reliance Retail acquired a 60% stake in NetMeds parent Vitalic Health for ₹620 crore, entering e-pharmacy to rival Amazon, amid regulatory uncertainty and
Key facts
- 60% stake
- ₹620 crore
- 100% ownership
- 20% stake by 2024
- net loss ₹184.3 crore FY20
- net loss ₹164.15 crore
- 19.59% ownership
Why this matters
This controlling-stake acquisition validates e-pharmacy as a consolidation battleground, so map remaining independent platforms and chemist-network assets now while regulatory uncertainty still depresses valuations.
What to watch
- Central e-pharmacy regulation / draft rules notification
- AIOCD strikes or litigation filings
- PharmEasy and Amazon India funding or pricing responses
- NetMeds order volume and burn-rate disclosures post-integration
- Reliance quarterly retail segment commentary on digital commerce
- Integrate NetMeds catalog into JioMart and Reliance apps
- Launch discount and delivery subsidies to capture urban market share
- Build offline chemist partnerships to blunt AIOCD opposition
- Expand fulfillment/warehousing for pharma cold-chain and last-mile